glp-1 news nov 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford GLP-1 Pipeline Update: November 2025

And look at her amplifying the voices of people who are saying, I care enough about my coaching clients and training clients to unlearn, relearn, and own some stuff. Thats powerful, right

Clinical trials for Rybelsus and Ozempic have shown that the most common side effects for both formulations are gastrointestinal, like nausea, vomiting, diarrhea, abdominal pain, and constipation

The EM data were collected at iNANO Cryo-Electron Microscopy Facility (EMBION), Aarhus University, Denmark and with the support of facility manager Dr

If you are considering medical weight loss in Atlanta, understanding how these GLP-1 therapies compare can help you make a more informed decision

This glucose dependent mechanism means they lower blood sugar primarily when its elevated reducing hypoglycemia risk compared with older diabetes medications

Recent studies suggest that Wegovy users are 4 to 7 times more likely to develop NAION compared to non-users